Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Katerina Fountoulaki , Nikolaos Dagres , Efstathios K Iliodromitis Added: 3 years ago
Heart failure (HF) is a feared endpoint for most cardiovascular diseases and is a major cause of morbidity and mortality. The worldwide prevalence of HF is between 2 and 3 % and rises sharply at around 75 years of age, so that the prevalence in 70- to 80-year-old people is between 10–20 %. With a 50 % 5-year survival rate, HF is predicted to be the leading cause of all morbidity by 2020.1,2… View more

Heart Failure
Foreword

Article

Author(s): Andrew JS Coats , Giuseppe Rosano Added: 3 years ago
We have great pleasure in recommending this second issue of Cardiac Failure Review to our readers. We have a panel of exceptional experts who have reviewed topical issues varying from fundamental science underpinning the diseased heart muscle to practical advice on clinical management from the acute presentation and cardiogenic shock through to patient self-management. In this second issue we… View more

Heart Failure
The Use of App-based Follow-up of Cardiac Implantable Electronic Devices
Author(s): Paul Richard Roberts , Mohamed Hassan ElRefai Added: 4 years ago
‘Digital health’ increasingly surrounds us in the clinical environment, although it is not always embraced among all healthcare professionals. Modern technologies and digital appliances have a significant impact on the way we care for patients by offering innovative ways to converge technology, connectivity and people. This should translate into improved care and clinical outcomes.1 The term is… View more

Heart Failure

Electrophysiology & Arrhythmia
Hospice Use Among Patients with Heart Failure
Author(s): Sarah H Cross , Arif H Kamal , Donald H Taylor Jr , et al Added: 3 years ago
Heart failure (HF) is estimated to affect 26 million people worldwide and is responsible for an annual global economic burden of US$108 billion.1,2 An ageing population and a reduction in mortality from other conditions such as acute MI are expected to result in an increased HF prevalence throughout much of the world.1,3–6 The prevalence of HF has particularly increased among those aged 85 years… View more

Heart Failure
Pirfenidone for Lung and Cardiac Disorders
Author(s): Alberto Aimo , Giosafat Spitaleri , Dario Nieri , et al Added: 2 years ago

Heart Failure
Representation of Women Physicians in Heart Failure Clinical Practice
Author(s): Ersilia M DeFilippis , Yasbanoo Moayedi , Nosheen Reza Added: 3 years ago

Demographic
Cell Therapy in Heart Failure with Preserved Ejection Fraction
Author(s): Sabina Frljak , Gregor Poglajen , Bojan Vrtovec Added: 2 years ago

Heart Failure
Red Cell Volume Distribution Width as Another Biomarker
Author(s): Artemio García-Escobar , Juan Manuel Grande Ingelmo Added: 3 years ago
To the Editor, We congratulate Nadar and Shaikh for their excellent review of the use of biomarkers in heart failure (HF), as well as the new biomarkers currently under investigation.1 Red blood cell distribution width (RDW) is a measure of the heterogeneity of distribution of red blood cell size. A high RDW implies a large variation in red blood cell (RBC) size (anisocytosis) and a low RDW… View more

Heart Failure
Red Cell Distribution Width as a Biomarker for Heart Failure: Still Not Ready for Prime-Time
Author(s): Sunil K Nadar , Muhammad Mujtaba Shaikh Added: 3 years ago
Dear Editor, We would like to thank García-Escobar and Ingelmo for their letter regarding our article on the use of biomarkers in routine clinical care for heart failure.1,2 It was with interest that we read their comments on the use of red cell volume distribution width (RDW) as another biomarker for use in the management of patients with heart failure. As mentioned in their letter, RDW is a… View more

Heart Failure
Telecommunication for Advance Care Planning in Heart Failure
Author(s): Rekha V Thammana , Sarah J Goodlin Added: 2 years ago

Standards & Guidelines

Heart Failure